Some genetic disorders—such as cystic fibrosis, hemophilia and Tay Sachs disease—involve many mutations in a person's genome, ...

Biotech firm Metagenomi said it is using artificial intelligence chips from Amazon.com's cloud computing unit to power some ...

Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...

Researchers have developed an improved method of gene editing that is precise, more efficient than other similar methods and ...

We have the tech to make designer babies but we are not ready for it yet. Read more at straitstimes.com. Read more at straitstimes.com.

Biotech company Metagenomi ( NASDAQ: MGX) is utilizing artificial intelligence chips from Amazon Web Services ( AMZN) to ...

With Eli Lilly's recent acquisition of Verve Therapeutics and its PCSK9 candidate, delve into what the target represents.

A one-time gene-editing therapy, exagamglogene autotemcel (exa-cel), has demonstrated sustained and clinically meaningful ...

Gene editing, led by CRISPR, is expanding rapidly beyond medical applications, offering new opportunities across various biotech industries. Technological breakthroughs are fueling acceleration and ...

The researchers used Crispr-Cas9 “genetic scissors” technology to make the edit in pig zygotes — the cells formed from the ...